Targeted complement activating molecules and methods of use thereof

TW202637591APending Publication Date: 2026-09-16OMENOS CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115104173
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-02-04
Filing Date
2026-02-03
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001077149_001
    Figure TWG2TA001077149_001
  • Figure TWG2TA001077149_002
    Figure TWG2TA001077149_002
  • Figure TWG2TA001077149_003
    Figure TWG2TA001077149_003
Patent Text Reader

Abstract

In one aspect, the present disclosure provides targeted complement activating molecules comprising a target binding domain and a complement activating serine protease effector domain. In some embodiments, the target binding domain is derived from an antibody or an antigen-binding fragment thereof. Also provided are compositions and methods for treating a microbial infection using targeted complement activating molecules.
Need to check novelty before this filing date? Find Prior Art